Your browser doesn't support javascript.
loading
Relationship of response and survival in patients with relapsed and refractory multiple myeloma treated with pomalidomide plus low-dose dexamethasone in the MM-003 trial randomized phase III trial (NIMBUS).
Moreau, Philippe; Weisel, Katja C; Song, Kevin W; Gibson, Craig J; Saunders, Owain; Sternas, Lars Axel; Hong, Kevin; Zaki, Mohamed H; Dimopoulos, Meletios A.
Afiliação
  • Moreau P; a Hematology Department , University Hospital Hôtel-Dieu , Nantes , France.
  • Weisel KC; b University of Tübingen , Tübingen , Germany.
  • Song KW; c Vancouver General Hospital , Vancouver , BC , Canada.
  • Gibson CJ; d Celgene Corporation , Summit , NJ , USA.
  • Saunders O; e BresMed Health Solutions , Sheffield , UK.
  • Sternas LA; d Celgene Corporation , Summit , NJ , USA.
  • Hong K; d Celgene Corporation , Summit , NJ , USA.
  • Zaki MH; d Celgene Corporation , Summit , NJ , USA.
  • Dimopoulos MA; f Alexandra Hospital , Athens , Greece.
Leuk Lymphoma ; 57(12): 2839-2847, 2016 12.
Article em En | MEDLINE | ID: mdl-27173785
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article